![]() |
市場調査レポート
商品コード
1738801
血圧モニタリングデバイス市場:製品タイプ、エンドユーザー、地域別、2026年~2032年Blood Pressure Monitoring Devices Market by Product Type, End-user, & Region for 2026-2032 |
||||||
|
血圧モニタリングデバイス市場:製品タイプ、エンドユーザー、地域別、2026年~2032年 |
出版日: 2025年05月06日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2~3営業日
|
血圧モニタリングデバイス市場は、世界の高血圧の有病率の増加、モニタリングデバイスの技術進歩、定期的な血圧モニタリングの重要性に関する意識の高まりによって上向きに推移しています。Verified Market Researchのアナリストによると、血圧モニタリングデバイス市場は2024年の19億4,000万米ドルから予測期間中に34億1,000万米ドルの評価に達すると推定されます。
血圧モニタリングデバイス市場の急拡大は、主に高齢者人口の増加、心血管疾患の発生率の増加、在宅ヘルスケア機器の需要の増加によってもたらされています。これらの要因によって、市場は2026年から2032年にかけてCAGR 7.30%で成長します。
血圧モニタリングデバイス市場定義/概要
血圧モニタリングデバイスは、血管壁に対する循環血液の圧力を測定するために使用される医療機器と定義されます。これらの機器は、心臓病、脳卒中、その他の健康問題のリスクを大幅に増大させる高血圧の診断と管理に極めて重要です。
さらに、血圧モニタリングデバイスの用途は多岐にわたり、ヘルスケアに不可欠です。病院や診療所では、定期検診や緊急医療に活用されています。在宅医療では、高血圧患者や発症リスクのある患者の定期的な血圧モニタリングに使用されます。さらに、外来血圧モニタリングデバイスは、24時間にわたる患者の血圧をより包括的に把握し、より正確な診断と治療計画の立案に役立ちます。
高血圧と診断される人の増加は、血圧モニタリングデバイス産業の主要な促進要因です。世界保健機関(WHO)によると、世界中で30~79歳の推定12億8,000万人が高血圧を患っており、その大多数が低・中所得国に居住しています。高血圧の有病率の増加は、効果的で利用しやすい血圧モニタリングデバイスの需要を促進しています。
高齢者は心血管疾患に対してより脆弱であるため、世界人口の高齢化は血圧モニタリングデバイス産業のもう一つの主要な促進要因です。国連によると、65歳以上の世界人口は2050年までに2倍以上に増加し、15億人以上に達すると予想されています。この人口動態の変化により、高齢者ケアや慢性疾患管理の一環として、血圧モニタリングデバイスの需要が高まると予測されています。
さらに、在宅ヘルスケアソリューションは、特に高血圧などの慢性疾患の管理用として人気が高まっています。米国疾病予防管理センター(CDC)の調査によると、米国の成人の約46%が高血圧症であり、効果的な管理手法として家庭血圧モニタリングが推奨されています。簡単な家庭用モニタリング機器へのニーズの高まりが、業界を前進させています。
正確で一貫性のある測定値は、血圧モニタリングデバイスを使用する上で最も困難な側面の1つです。多くのユーザーがこれらの機器を正しく使用せず、誤診や不適切な高血圧治療を招いています。これらの機器の適切な使用方法に関する患者教育が不十分であることが、不満や技術に対する信頼の欠如につながります。メーカーは、ユーザーエクスペリエンスを向上させ、読み取りエラーを減らすために、ユーザーフレンドリーなデザインと広範なトレーニング教材に投資しなければならないです。
もう一つの大きな問題は、血圧測定装置をヘルスケアシステムや電子カルテ(EHR)に統合することです。既存の機器の多くはヘルスケア・プラットフォームから独立しているため、医師が患者のデータをリアルタイムで取得し評価することが困難です。このミスマッチが効率的なモニタリングと迅速な介入を妨げています。この障壁を克服し、血圧管理の全体的な有効性を向上させるためには、機器とヘルスケアシステム間のデータ交換と相互運用性のための標準規格を構築する取り組みが不可欠です。
さらに、血圧モニタリングデバイスのコストと入手しやすさが、特に十分なサービスを受けていない人々への普及の課題となっています。これらの機器の価格は時間の経過とともに低下しているもの、一部の個人、特に保険に加入していない人々にとっては、手頃な価格が依然として問題です。さらに、低所得の患者は、その潜在的な利点にもかかわらず、このような機器への投資を優先しない危険性があります。このようなアクセシビリティの問題に対処することは、血圧モニタリング技術をより多くの人々、特に効果的な高血圧管理から最も恩恵を受ける地域社会に確実に普及させるために極めて重要です。
The blood pressure monitoring devices market is driven upwards by the increasing prevalence of hypertension globally, technological advancements in monitoring devices, and growing awareness about the importance of regular blood pressure monitoring. According to analysts from Verified Market Research, the blood pressure monitoring devices market is estimated to reach a valuation of USD 3.41 Billion over the forecast period, up from USD 1.94 Billion valued in 2024.
The rapid expansion of the blood pressure monitoring devices market is primarily driven by the rising geriatric population, increasing incidence of cardiovascular diseases, and the growing demand for home healthcare devices. These factors are enabling the market to grow at a CAGR of 7.30 % from 2026 to 2032.
Blood Pressure Monitoring Devices Market: Definition/ Overview
Blood pressure monitoring devices are defined as medical instruments used to measure the pressure of circulating blood against the walls of blood vessels. These devices are crucial in the diagnosis and management of hypertension, a condition that significantly increases the risk of heart disease, stroke, and other health problems.
Furthermore, the applications of blood pressure monitoring devices are diverse and essential in healthcare. They are utilized in hospitals and clinics for routine check-ups and emergency care. In-home care settings, these devices are used for regular monitoring of blood pressure by patients with hypertension or those at risk of developing it. Additionally, ambulatory blood pressure monitoring devices are employed to provide a more comprehensive picture of a patient's blood pressure over 24 hours, aiding in more accurate diagnosis and treatment planning.
The increasing number of persons diagnosed with hypertension is a major driver of the blood pressure monitoring equipment industry. According to the World Health Organization (WHO), an estimated 1.28 billion persons aged 30-79 have hypertension worldwide, with the majority residing in low- and middle-income nations. The growing prevalence of hypertension is driving demand for effective and accessible blood pressure monitoring devices.
The aging global population is another key driver of the blood pressure monitoring device industry, as older persons are more vulnerable to cardiovascular disease. According to the United Nations, the worldwide population of persons aged 65 and up is expected to more than double by 2050, reaching more than 1.5 billion. This demographic shift is predicted to boost demand for blood pressure monitoring devices as part of elderly care and chronic illness management.
Furthermore, home-based healthcare solutions are becoming increasingly popular, particularly for controlling chronic illnesses such as hypertension. According to research from the Centers for Disease Control and Prevention (CDC), roughly 46% of adults in the United States have hypertension, and home blood pressure monitoring is recommended as a technique for effective management. The growing need for easy, at-home monitoring devices is propelling the industry forward.
Accurate and consistent readings are one of the most difficult aspects of using blood pressure monitoring equipment. Many users do not utilize these devices correctly, resulting in a misdiagnosis or improper hypertension treatment. Inadequate patient education on how to use these devices properly leads to dissatisfaction and a lack of faith in the technology. Manufacturers must invest in user-friendly designs and extensive training materials to enhance the user experience and reduce reading errors.
Another big problem is integrating blood pressure monitoring devices into healthcare systems and electronic health records (EHR). Many existing devices are independent of healthcare platforms, making it difficult for doctors to obtain and evaluate patient data in real-time. This mismatch impedes efficient monitoring and prompt interventions. Efforts to build standardized standards for data exchange and interoperability between devices and healthcare systems are critical for overcoming this barrier and improving the overall effectiveness of blood pressure management.
Furthermore, the cost and accessibility of blood pressure monitoring devices pose challenges to widespread adoption, particularly in underserved populations. Although prices for these devices have decreased over time, affordability remains an issue for some individuals, especially those without insurance coverage. Furthermore, there is a risk that lower-income patients do not prioritize investing in such devices, despite their potential benefits. Addressing these accessibility issues is crucial to ensuring that blood pressure monitoring technologies reach a broader audience, particularly in communities that benefit the most from effective hypertension management.
According to VMR analysis, the digital blood pressure monitors segment is estimated to dominate the market in the product type segment during the forecast period. The ease of use and automatic operation of digital blood pressure monitors are cited as key factors driving their popularity. These devices require minimal training to operate and provide easy-to-read digital displays, making them suitable for home use and self-monitoring. The convenience factor is contributing significantly to their widespread adoption.
The ability of digital blood pressure monitors to store and track blood pressure readings over time is recognized as a valuable feature. Many models store multiple readings and calculate averages, providing users and healthcare providers with a more comprehensive view of blood pressure trends. This functionality is beneficial for long-term monitoring and management of hypertension, driving the demand for these devices.
Furthermore, the integration of digital blood pressure monitors with smartphone apps and health-tracking platforms is seen as a major driver of their popularity. These connected devices allow users to easily log, analyze, and share their blood pressure data with healthcare providers. The ability to seamlessly integrate blood pressure monitoring into overall health management is appealing to both patients and healthcare professionals, contributing to the dominance of this segment in the market.
The home care settings segment is estimated to exhibit the highest growth within the blood pressure monitoring devices market during the forecast period. The growing preference for home-based care, especially among the elderly population, is identified as a key driver for this trend. Home blood pressure monitoring allows patients to take regular readings in a comfortable environment, potentially providing a more accurate representation of their typical blood pressure levels.
The rising healthcare costs and the push towards reducing hospital readmissions are cited as factors contributing to the growth of home care settings for blood pressure monitoring. Regular home monitoring helps detect blood pressure changes early, allowing for timely interventions and potentially reducing the need for emergency hospital visits or admissions. This aspect is particularly appealing to healthcare systems looking to manage costs and improve patient outcomes.
Furthermore, the COVID-19 pandemic is credited with accelerating the shift towards home-based care and monitoring. The need to minimize non-essential hospital visits has led to increased adoption of home blood pressure monitoring devices. This trend is expected to continue beyond the pandemic, as both patients and healthcare providers recognize the benefits of remote monitoring, further driving the growth of the home care settings segment.
According to VMR analysts, North America is estimated to dominate the blood pressure monitoring devices market during the forecast period. North America has a significant prevalence of hypertension, which is a key driver of the blood pressure monitoring devices market. According to the Centers for Disease Control and Prevention (CDC), half of all adults in the United States have high blood pressure, contributing to a growing demand for effective monitoring solutions. This high prevalence not only drives the need for blood pressure devices but also encourages individuals to seek regular monitoring to manage their condition effectively.
The rise of telehealth and remote patient monitoring solutions has significantly boosted the adoption of blood pressure monitoring devices in North America. The COVID-19 pandemic accelerated the integration of telemedicine into healthcare, enabling patients to monitor their blood pressure from home and share the data with healthcare providers. This shift has been supported by the U.S. Department of Health and Human Services (HHS), which has implemented policies to promote remote patient monitoring, making it easier for patients to access healthcare services while managing chronic conditions like hypertension.
Furthermore, North America's robust healthcare infrastructure and commitment to innovation play a crucial role in driving the blood pressure monitoring devices market. The U.S. invests heavily in healthcare research and development, with agencies such as the National Institutes of Health (NIH) supporting advancements in medical technology. This environment fosters the development of cutting-edge blood pressure monitoring devices, enhancing their effectiveness and usability. As a result, healthcare providers are more likely to adopt these technologies to improve patient care and outcomes in managing hypertension.
The Asia Pacific region is estimated to exhibit the highest growth within the blood pressure monitoring devices market during the forecast period. The Asia-Pacific region is witnessing a rising incidence of hypertension, which is a significant driver for the blood pressure monitoring devices market. According to the World Health Organization (WHO), an estimated 1.5 billion people globally have hypertension, with a substantial portion residing in Asia. This growing prevalence underscores the urgent need for effective monitoring solutions, driving demand for advanced blood pressure monitoring devices in the region.
There is a marked shift toward preventive healthcare in the Asia-Pacific region, with governments and healthcare organizations promoting regular health check-ups and monitoring of chronic conditions. Countries like Japan and Australia have initiated public health campaigns aimed at raising awareness about hypertension and its complications. This emphasis on preventive care encourages individuals to invest in blood pressure monitoring devices for home use, facilitating early detection and management of hypertension.
Furthermore, the Asia-Pacific region is experiencing significant advancements in medical technology, particularly in the field of blood pressure monitoring devices. Innovations such as wearable technology and smartphone integration are making it easier for consumers to monitor their blood pressure accurately and conveniently. Government initiatives in countries like China and South Korea, aimed at promoting research and development in health technology, further contribute to the growth of the blood pressure monitoring devices market, ensuring access to cutting-edge solutions for managing hypertension effectively.
The blood pressure monitoring devices market's competitive landscape is characterized by a mix of established medical device manufacturers and innovative startups, all striving to gain market share through technological advancements and strategic partnerships.
Some of the prominent players operating in the blood pressure monitoring devices market include:
Omron Healthcare, Inc.
A&D Company, Limited
Welch Allyn (Hill-Rom Holdings, Inc.)
SunTech Medical, Inc. (Halma plc)
Rossmax International Ltd.
Spacelabs Healthcare (OSI Systems, Inc.)
GE Healthcare
Koninklijke Philips N.V.
Schiller AG
Microlife Corporation
In October 2021, Omron Healthcare launched its latest innovation, the "Omron Complete," a blood pressure monitor integrated with EKG technology. This device allows users to monitor both blood pressure and heart rhythm at home, offering enhanced capabilities for detecting atrial fibrillation and other cardiovascular conditions. This launch further solidified Omron's leadership in the home healthcare market.
In July 2020, Philips introduced a new series of wearable blood pressure monitoring devices designed for continuous monitoring of patients in hospitals. These devices help healthcare providers track blood pressure fluctuations in real time, improving patient outcomes by allowing for timely interventions. Philips' expansion in the wearable healthcare technology sector underscores its commitment to advancing remote patient monitoring solutions.